Appili Therapeutics Inc. (TSX:APLI)

Appili Therapeutics Statistics

Total Valuation

TSX:APLI has a market cap or net worth of CAD 2.57 million. The enterprise value is 14.44 million.

Market Cap	2.57M
Enterprise Value	14.44M

Important Dates

The next estimated earnings date is Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

TSX:APLI has 128.37 million shares outstanding.

Current Share Class	128.37M
Shares Outstanding	128.37M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.06%
Owned by Institutions (%)	n/a
Float	114.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	12.86
PB Ratio	-0.16
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.70
EV / Sales	72.32
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-82.72

Financial Position

The company has a current ratio of 0.05

Current Ratio	0.05
Quick Ratio	0.03
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-70.02
Interest Coverage	-5.14

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-406.02%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	50.00%
Revenue Per Employee	28,527
Profits Per Employee	-362,133
Employee Count	7
Asset Turnover	0.17
Inventory Turnover	n/a

Taxes

In the past 12 months, TSX:APLI has paid 83,494 in taxes.

Income Tax	83,494
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -42.86% in the last 52 weeks. The beta is 0.14, so TSX:APLI's price volatility has been lower than the market average.

Beta (5Y)	0.14
52-Week Price Change	-42.86%
50-Day Moving Average	0.03
200-Day Moving Average	0.02
Relative Strength Index (RSI)	45.38
Average Volume (20 Days)	55,671

Short Selling Information

The latest short interest is 12,229, so 0.01% of the outstanding shares have been sold short.

Short Interest	12,229
Short Previous Month	47,047
Short % of Shares Out	0.01%
Short % of Float	0.01%
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSX:APLI had revenue of CAD 199,688 and -2.53 million in losses. Loss per share was -0.02.

Revenue	199,688
Gross Profit	199,688
Operating Income	-7.50M
Pretax Income	-2.45M
Net Income	-2.53M
EBITDA	-7.48M
EBIT	-7.50M
Loss Per Share	-0.02

Balance Sheet

The company has 348,679 in cash and 12.22 million in debt, with a net cash position of -11.87 million or -0.09 per share.

Cash & Cash Equivalents	348,679
Total Debt	12.22M
Net Cash	-11.87M
Net Cash Per Share	-0.09
Equity (Book Value)	-15.61M
Book Value Per Share	-0.13
Working Capital	-15.01M

Cash Flow

In the last 12 months, operating cash flow was -173,868 and capital expenditures -702, giving a free cash flow of -174,570.

Operating Cash Flow	-173,868
Capital Expenditures	-702
Free Cash Flow	-174,570
FCF Per Share	-0.00

Margins

Gross Margin	100.00%
Operating Margin	-3,755.31%
Pretax Margin	-1,227.64%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSX:APLI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-98.74%
FCF Yield	-6.80%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSX:APLI has an Altman Z-Score of -193.52 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-193.52
Piotroski F-Score	2